Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Caribou

"It does loads of mad sh*t that I still need to work out": Watch Four Tet jam on the drum machine given to him by Floating Points and Caribou

The pair generously gifted the Coachella-headlining producer and DJ a Soma Laboratories Pulsar-23 percussion synth

MusicRadar

Who does the best hot chips in Canberra? We put potato to the test

Forget all that fish and chips on the coast thing. Eat local.

The Canberra Times

Anthony Naples: "Any time I get new gear, it's just a way for me to resist getting down to actually making music"

Anthony Naples' fifth album is a masterwork of musical escapism. He talks us through how orbs was made, his relationship with gear, and how 16 channels are more than enough

MusicRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

Stop charging extra for non-dairy milk!

Those who can't tolerate dairy shouldn't be penalized or expected to pay extra for their choice of milk

Salon

Pure bliss, horny electro and an anti-ableism tirade: Meredith music festival celebrates 30 years of its big, weird family

Caribou, Courtney Barnett and Tasman Keith were among the highlights of the beloved BYO camping festival, which continues to bring out the best

The Guardian - AU

Review: Bonobo + Caribou at Warehouse Project

Warehouse Project kicked off the bank holiday weekend with live sets from co-headliners Bonobo and Caribou – a musical masterclass

Manchester Evening News

Analysts Remain Bullish Despite Caribou's Allogeneic CAR-T Hit By Durability

Caribou Biosciences Inc (NASDAQ:CRBU) announced the presentation of additional initial clinical data from its ANTLER Phase 1 trial for CB-010 in relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL). Following a single dose at the initial dose level of 40 million CAR-T cells, a 100% complete response (CR) rate (6 of 6…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

What's Going On With Caribou Biosciences Shares Today?

Caribou Biosciences, Inc. (NASDAQ: CRBU) shares are trading lower after the company reported additional data from its CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.

Benzinga

Favourite festival sold out? Here are the best alternatives

After two long years, festivals are back – but tickets are in short supply. Here are some options if you’ve missed out, featuring rave-jazz parties, fairground rides and organic psychedelia

The Guardian - UK

The Canadian Government Couldn't Stop Bitcoin

Honk Honk HODL raised more than $1 million of bitcoin for the Canadian truckers. About two-thirds of it got to them.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.